Adapalene for Acne Scars: What the Research Actually Says It Can

The most common question people ask after starting adapalene is some version of: will this help my scars? It's a reasonable thing to ask. But "acne scars" is being used to describe at least three different conditions that respond very differently to treatment — and conflating them is where most of the confusion comes from.

The flat dark marks left after a breakout heals? Those are post-inflammatory hyperpigmentation. The retinoid addresses them.

The indented pitting and textured depressions — ice pick, boxcar, rolling scars? Those are atrophic scars, and the evidence is thin at OTC concentrations, though more promising at prescription-strength 0.3%.

The raised, thickened keloid or hypertrophic scars? These don't respond to topical retinoids at all.

Getting clear on which one you have is the first step toward understanding what a retinoid can actually do for your skin.

The Three Types of Post-Acne Marks — and Which the Research Supports

Post-Inflammatory Hyperpigmentation (PIH)

This is what most people mean when they say "acne scars." PIH is the flat, darkened discoloration left behind after an acne lesion heals. It's not a true scar in the structural sense — no permanent tissue damage has occurred. The pigmentation is the result of excess melanin deposited during the inflammatory response.

PIH presents as brown, reddish, or grayish flat marks depending on skin depth and Fitzpatrick skin type. It's far more common and more pronounced in medium-to-deep skin tones. In a 2025 Acta Dermato-Venereologica review, PIH prevalence in acne patients was reported at 65% in African American patients, 48% in Hispanic patients, and 25% in Caucasian patients.

This is the category a topical retinoid actually helps. The cell turnover mechanism that clears comedones also accelerates replacement of hyperpigmented cells with newer, unpigmented ones. The anti-inflammatory suppression reduces the melanin deposition trigger in new lesions. At 0.1% OTC, the evidence is real and consistent across multiple studies.

Atrophic Acne Scars

These are structural. Ice pick scars are narrow, deep, pitted channels. Boxcar scars are wider, angular depressions with defined edges. Rolling scars create a wavy, undulating texture from subcutaneous fibrous tissue pulling the skin surface downward. All three involve loss of collagen and dermal matrix — physical tissue damage that topical cell turnover can't fully address.

The evidence here is limited at OTC concentrations. Prescription-strength 0.3% gel has been studied specifically for atrophic scarring, with exploratory evidence suggesting some improvement via collagen stimulation. But OTC 0.1% doesn't carry the same data.

If atrophic scarring is the primary concern, a dermatologist visit is the right next step. Microneedling, fractional laser resurfacing, and subcision are the evidence-based approaches.

Hypertrophic and Keloid Scars

These are raised, thickened, fibrous scars formed by collagen overproduction during healing. They're more common on the chest, back, and jawline than the central face. There's no established role for topical retinoids here — steroid injections, silicone gel sheeting, laser therapy, and excision are the relevant approaches.

What the Research Shows for PIH

The evidence for topical retinoids in PIH is consistent across multiple trial designs.

A 2024 systematic review in the Journal of the European Academy of Dermatology, analyzing PIH treatment outcomes in skin of colour patients, confirmed that adapalene 0.1% gel produced a decrease in macule number and density — consistent with the open-label data above.

Topical retinoids as a class showed partial PIH improvement at 12 weeks across multiple studies. The tolerability advantage matters here: irritant contact dermatitis from stronger retinoids like tretinoin and tazarotene can itself trigger new PIH in reactive skin. The lower irritation profile of adapalene makes it the more appropriate choice for this concern.

This second finding is the one most people miss. The most powerful role adapalene may play in the scarring picture is preventive — stopping the inflammatory acne that causes scarring before the damage occurs. Fewer inflammatory papules means fewer opportunities for both PIH and structural scarring to form.

The Atrophic Scar Question — What 0.3% Adds

For people with existing atrophic scars, there's a more nuanced but more limited story at prescription-strength concentrations.

This is exploratory, not definitive — and it's 0.3% prescription, not OTC 0.1%. The mechanism is plausible: collagen synthesis stimulation similar to what the retinoid produces in photoaged skin, where the same feature of dermal matrix loss is present.

If you're managing existing atrophic scarring and want a retinoid alongside procedural treatments, this is worth discussing with a dermatologist who can prescribe the 0.3% formulation. OTC 0.1% is the right tool for PIH, active acne, and scar prevention — not for structural scarring that already exists.

The Mechanism Behind PIH Fading

Understanding why a retinoid helps with PIH makes the timeline expectations more realistic.

When an inflammatory lesion heals, the immune response deposits excess melanin as a byproduct of the cascade. That melanin sits in the upper layers of the dermis and epidermis, presenting as the flat dark or reddish marks familiar to anyone who's dealt with acne.

Two pathways account for the fading. First, accelerated cell turnover replaces hyperpigmented cells with newer, less pigmented ones over successive skin cycles — each 28-day cycle moves pigmented cells closer to the surface and eventually off the skin.

Second, anti-inflammatory signaling suppression (TLR-2 and 15-lipoxygenase) reduces the melanin deposition trigger in new lesions, so future breakouts leave lighter marks.

The result: existing PIH fades gradually, and new PIH forms less readily.

SPF Is Not Optional Here

For PIH specifically, sunscreen is doing active work — not just protecting against future damage.

UV exposure stimulates melanocyte activity, which directly worsens existing PIH and slows fading. While the retinoid accelerates pigmented cell turnover, unprotected sun exposure simultaneously re-triggers melanin production in the same areas. The net effect is slower fading, or in some cases, deeper pigmentation.

Broad-spectrum SPF 30 or higher, every morning without exception, is part of the PIH protocol — not an add-on. This holds for all skin tones, but it's especially critical in medium-to-deep Fitzpatrick types where UV-triggered PIH deepening is well-documented.

The increased photosensitivity from accelerated cell turnover also applies — newer surface cells are more vulnerable to UV damage regardless of PIH status.

What to Pair With Adapalene for Faster PIH Fading

The retinoid alone addresses PIH, but supporting ingredients can improve the fading timeline.

Niacinamide (5–10%) is the most practical pairing. It interrupts melanin transfer from melanocytes to surrounding keratinocytes, reducing new pigment deposition. It also reduces retinoid-related redness — doubly relevant here since irritation from retinoids can itself trigger PIH in reactive skin.

Azelaic acid is a strong complement via a different mechanism. It's a mild tyrosinase inhibitor, reducing melanin synthesis at the source, while also being keratolytic and anti-inflammatory.

Using it on alternate nights alongside adapalene covers more mechanisms than either alone. The full comparison is in our adapalene vs. azelaic acid guide.

Vitamin C in the AM routine — not on adapalene nights — adds antioxidant and melanin-inhibiting properties. Keep it on a separate morning schedule and it complements the retinoid without adding irritation load.

What to avoid: strong acids, fragrance, and high-concentration benzoyl peroxide on retinoid nights. Irritant contact dermatitis from these combinations can generate new PIH while you're working to fade existing marks.

The Realistic Fading Timeline

PIH from mild-to-moderate inflammatory acne typically fades in 3–6 months with consistent SPF use and a retinoid, even without targeted treatment. With a well-structured routine, that timeline may compress — but not dramatically.

The fading happens faster with active intervention, and new marks that form are lighter. Individual timelines vary based on Fitzpatrick skin type, pigmentation depth (epidermal PIH fades faster than dermal), SPF consistency, and how well active lesion formation has been controlled.

The honest framing: adapalene is a strong option for PIH, but it's not a spot treatment. It works by improving the overall skin environment over time.

For the full PM routine, the adapalene skincare routine covers layering, timing, and what to avoid.

For product options, the adapalene gel guide covers every OTC formulation with formulation notes. And for realistic expectations on the full results timeline, our adapalene before and after guide walks through what weeks 1 through 12 actually look like.

Consult a dermatologist before starting if you're pregnant, nursing, or managing a chronic skin condition. Do not use retinoids during pregnancy.

‍